PL437115A1 - sztuczna klatka białkowa zawierająca zamknięty w niej transportowany ładunek - Google Patents

sztuczna klatka białkowa zawierająca zamknięty w niej transportowany ładunek

Info

Publication number
PL437115A1
PL437115A1 PL437115A PL43711521A PL437115A1 PL 437115 A1 PL437115 A1 PL 437115A1 PL 437115 A PL437115 A PL 437115A PL 43711521 A PL43711521 A PL 43711521A PL 437115 A1 PL437115 A1 PL 437115A1
Authority
PL
Poland
Prior art keywords
artificial
transported
artificial protein
cage containing
trap
Prior art date
Application number
PL437115A
Other languages
English (en)
Inventor
Jonathan Heddle
Artur BIELA
Yusuke Azuma
Antonina Naskalska
Kinga BORZĘCKA-SOLARZ
Jan RÓŻYCKI
Izabela STUPKA
Original Assignee
Uniwersytet Jagielloński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagielloński filed Critical Uniwersytet Jagielloński
Priority to PL437115A priority Critical patent/PL437115A1/pl
Priority to EP22710453.6A priority patent/EP4298116A1/en
Priority to JP2023551176A priority patent/JP2024507900A/ja
Priority to CA3209417A priority patent/CA3209417A1/en
Priority to MX2023009814A priority patent/MX2023009814A/es
Priority to US18/547,242 priority patent/US20240181077A1/en
Priority to CN202280028742.8A priority patent/CN117157311A/zh
Priority to CN202280030041.8A priority patent/CN117203225A/zh
Priority to PCT/PL2022/050009 priority patent/WO2022182260A1/en
Priority to US18/547,256 priority patent/US20240122868A1/en
Priority to EP22710454.4A priority patent/EP4298117A1/en
Priority to CN202280030038.6A priority patent/CN117203224A/zh
Priority to CA3209414A priority patent/CA3209414A1/en
Priority to PCT/PL2022/050010 priority patent/WO2022182261A1/en
Priority to JP2023551178A priority patent/JP2024507379A/ja
Priority to EP22710452.8A priority patent/EP4298115A1/en
Priority to JP2023551177A priority patent/JP2024507901A/ja
Priority to CA3209412A priority patent/CA3209412A1/en
Priority to PCT/PL2022/050011 priority patent/WO2022182262A1/en
Priority to US18/547,274 priority patent/US20240139339A1/en
Publication of PL437115A1 publication Critical patent/PL437115A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Przedmiotem niniejszego wynalazku jest sztuczna klatka TRAP obejmująca wybraną liczbę pierścieni TRAP i zamknięty w niej transportowany ładunek. Przedmiotem zgłoszenia jest sposób wykonania sztucznej klatki TRAP jej zastosowanie, sposób leczenia osoby wymagającej leczenia, cierpiącej na schorzenia z wybranej grupy, który to sposób obejmuje podawanie skutecznej terapeutycznie ilości sztucznej klatki TRAP, zawierającej jeden lub więcej ładunków transportowanych wewnątrz, oraz sposób szczepienia osoby wymagającej szczepienia przeciw schorzeniu z wybranej grupy, który to sposób obejmuje podawanie skutecznej terapeutycznie ilości sztucznej klatki TRAP, zawierającej jeden lub więcej ładunków, transportowanych wewnątrz.
PL437115A 2021-02-24 2021-02-24 sztuczna klatka białkowa zawierająca zamknięty w niej transportowany ładunek PL437115A1 (pl)

Priority Applications (20)

Application Number Priority Date Filing Date Title
PL437115A PL437115A1 (pl) 2021-02-24 2021-02-24 sztuczna klatka białkowa zawierająca zamknięty w niej transportowany ładunek
EP22710453.6A EP4298116A1 (en) 2021-02-24 2022-02-24 An artificial trap-cage, its use and method of preparing thereof
JP2023551176A JP2024507900A (ja) 2021-02-24 2022-02-24 外部に特定の分子で装飾された人工タンパク質ケージ
CA3209417A CA3209417A1 (en) 2021-02-24 2022-02-24 An artificial protein-cage comprising encapsulated therein a guest cargo
MX2023009814A MX2023009814A (es) 2021-02-24 2022-02-24 Una jaula trap artificial, su uso y método para preparación de la misma.
US18/547,242 US20240181077A1 (en) 2021-02-24 2022-02-24 An artificial protein-cage comprising encapsulated therein a guest cargo
CN202280028742.8A CN117157311A (zh) 2021-02-24 2022-02-24 在外部使用特定分子装饰的人工蛋白质笼
CN202280030041.8A CN117203225A (zh) 2021-02-24 2022-02-24 人工trap笼、其用途和其制备方法
PCT/PL2022/050009 WO2022182260A1 (en) 2021-02-24 2022-02-24 An artificial protein-cage decorated with particular molecules on the exterior
US18/547,256 US20240122868A1 (en) 2021-02-24 2022-02-24 An artificial trap-cage, its use and method of preparing thereof
EP22710454.4A EP4298117A1 (en) 2021-02-24 2022-02-24 An artificial protein-cage comprising encapsulated therein a guest cargo
CN202280030038.6A CN117203224A (zh) 2021-02-24 2022-02-24 包括封装在其中的客体货物的人工蛋白笼
CA3209414A CA3209414A1 (en) 2021-02-24 2022-02-24 An artificial trap-cage, its use and method of preparing thereof
PCT/PL2022/050010 WO2022182261A1 (en) 2021-02-24 2022-02-24 An artificial trap-cage, its use and method of preparing thereof
JP2023551178A JP2024507379A (ja) 2021-02-24 2022-02-24 人工ｔｒａｐケージ、その使用、およびその調製の方法
EP22710452.8A EP4298115A1 (en) 2021-02-24 2022-02-24 An artificial protein-cage decorated with particular molecules on the exterior
JP2023551177A JP2024507901A (ja) 2021-02-24 2022-02-24 その中にカプセル化されたゲストカーゴを含む人工タンパク質ケージ
CA3209412A CA3209412A1 (en) 2021-02-24 2022-02-24 An artificial protein-cage decorated with particular molecules on the exterior
PCT/PL2022/050011 WO2022182262A1 (en) 2021-02-24 2022-02-24 An artificial protein-cage comprising encapsulated therein a guest cargo
US18/547,274 US20240139339A1 (en) 2021-02-24 2022-02-24 An artificial protein-cage decorated with particular molecules on the exterior

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL437115A PL437115A1 (pl) 2021-02-24 2021-02-24 sztuczna klatka białkowa zawierająca zamknięty w niej transportowany ładunek

Publications (1)

Publication Number Publication Date
PL437115A1 true PL437115A1 (pl) 2022-08-29

Family

ID=83723924

Family Applications (1)

Application Number Title Priority Date Filing Date
PL437115A PL437115A1 (pl) 2021-02-24 2021-02-24 sztuczna klatka białkowa zawierająca zamknięty w niej transportowany ładunek

Country Status (2)

Country Link
CN (3) CN117203224A (pl)
PL (1) PL437115A1 (pl)

Also Published As

Publication number Publication date
CN117203225A (zh) 2023-12-08
CN117157311A (zh) 2023-12-01
CN117203224A (zh) 2023-12-08

Similar Documents

Publication Publication Date Title
Liebhart et al. Histomonosis in poultry: previous and current strategies for prevention and therapy
EA201792273A1 (ru) Композиции, содержащие комбинацию анти-pd-1 антитела и другого антитела
DE69932084D1 (de) Antikörperfragmente zur lokalen Behandlung von Augenerkrankungen
Giles et al. The SARS-CoV-2 B. 1.1. 7 variant and increased clinical severity—the jury is out
EA202190138A1 (ru) Анти-sirp-бета1 антитела и способы их использования
CR20210103A (es) Composición farmacéutica para usarse en el tratamiento o prevención de una enfermedad relacionada con c5 y método para tratar o prevenir una enfermedad relacionada con c5
EA202190310A1 (ru) Белок для лечения воспалительных заболеваний
AR114392A1 (es) Tratamiento de pacientes con enfermedad de fabry clásica
MA56124A (fr) Méthode sûre et efficace de traitement de l'arthrite psoriasique au moyen d'un anticorps spécifique anti-il23
PL437115A1 (pl) sztuczna klatka białkowa zawierająca zamknięty w niej transportowany ładunek
Lyke et al. Reduced T regulatory cell response during acute Plasmodium falciparum infection in Malian children co-infected with Schistosoma haematobium
MX2020009496A (es) Metodo para tratar asma o enfermedad alergica.
de Oliveira Silva et al. Establishment of an objective endpoint in mice model for caseous lymphadenitis vaccine trials
Martínez-Pérez et al. Immunological features of LPS from Ochrobactrum intermedium on sheep experimentally infected with Fasciola hepatica
EA202192865A1 (ru) Лечение головной боли с использованием антител к cgrp
Olmedo-Martín et al. Vitamin D in inflammatory bowel disease: biological, clinical and therapeutic aspects
EA202091563A1 (ru) Человеческие антитела к гемагглютинину вируса гриппа
Balicka-Ramisz et al. Gastrointestinal nematodes and the deworming of mouflon (Ovis aries musimon) from Goleniowska Forest in West Pomerania province, Poland
Kepil Özdemir et al. Analysis of the factors associated with diagnostic skin test positivity in immediate‐type hypersensitivity reactions due to proton pump inhibitors.
Williams Loneliness and social isolation and increased risk of coronary heart disease and stroke: clinical implications
EA202090205A1 (ru) Антагонист рецептора ангиотензина ii для предотвращения или лечения системных заболеваний у котов
Khatri et al. Fecundity of adult female worms were affected when Brugia malayi infected Mongolian gerbils were immunized with a multivalent vaccine (rBmHAXT) against human lymphatic filarial parasite
EA202192961A1 (ru) Ребамипид для применения в профилактике и/или лечении синуклеинопатий
Tuo et al. Repeated, drug-truncated infections with Ostertagia ostertagi elicit strong humoral and cell-mediated immune responses and confer partial protection in cattle
PL437114A1 (pl) Sztuczna klatka białkowa dekorowana na zewnątrz określonymi cząsteczkami